Grant Fullarton

3.6k total citations · 1 hit paper
57 papers, 1.8k citations indexed

About

Grant Fullarton is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Grant Fullarton has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 34 papers in Pulmonary and Respiratory Medicine and 24 papers in Gastroenterology. Recurrent topics in Grant Fullarton's work include Esophageal Cancer Research and Treatment (26 papers), Gastric Cancer Management and Outcomes (19 papers) and Esophageal and GI Pathology (16 papers). Grant Fullarton is often cited by papers focused on Esophageal Cancer Research and Treatment (26 papers), Gastric Cancer Management and Outcomes (19 papers) and Esophageal and GI Pathology (16 papers). Grant Fullarton collaborates with scholars based in United Kingdom, Ireland and Netherlands. Grant Fullarton's co-authors include Paul G. Horgan, Donald C. McMillan, William R. Murray, Sumanta Dutta, Andrew Crumley, Karin Oien, Kenneth E.L. McColl, Raf Bisschops, Erik J. Schoon and Bas L. Weusten and has published in prestigious journals such as JAMA, Gastroenterology and Oncogene.

In The Last Decade

Grant Fullarton

55 papers receiving 1.8k citations

Hit Papers

Radiofrequency Ablation vs Endoscopic Surveillance for Pa... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grant Fullarton United Kingdom 22 1.5k 947 435 385 109 57 1.8k
Giovanni Persico Italy 22 997 0.7× 526 0.6× 260 0.6× 325 0.8× 182 1.7× 66 1.5k
Leonardo Solaini Italy 21 809 0.6× 714 0.8× 204 0.5× 495 1.3× 99 0.9× 81 1.4k
Shingo Kanaji Japan 25 1.5k 1.0× 1.2k 1.3× 274 0.6× 739 1.9× 124 1.1× 184 2.1k
Hans‐Joachim Meyer Germany 17 2.1k 1.5× 2.5k 2.6× 589 1.4× 416 1.1× 146 1.3× 63 3.0k
Yoshinari Mochizuki Japan 27 868 0.6× 1.3k 1.4× 685 1.6× 496 1.3× 96 0.9× 87 1.7k
Shin‐ichi Kosugi Japan 23 1.2k 0.8× 1.0k 1.1× 184 0.4× 377 1.0× 353 3.2× 127 1.9k
Christoph Ackermann Switzerland 25 729 0.5× 457 0.5× 110 0.3× 447 1.2× 141 1.3× 59 1.5k
Paolo Morgagni Italy 27 1.3k 0.9× 2.2k 2.3× 999 2.3× 389 1.0× 132 1.2× 76 2.5k
Koshi Kumagai Japan 31 1.6k 1.1× 2.1k 2.2× 830 1.9× 720 1.9× 126 1.2× 141 2.8k
Yoshinori Hosoya Japan 25 904 0.6× 976 1.0× 537 1.2× 373 1.0× 308 2.8× 119 1.9k

Countries citing papers authored by Grant Fullarton

Since Specialization
Citations

This map shows the geographic impact of Grant Fullarton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant Fullarton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant Fullarton more than expected).

Fields of papers citing papers by Grant Fullarton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant Fullarton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant Fullarton. The network helps show where Grant Fullarton may publish in the future.

Co-authorship network of co-authors of Grant Fullarton

This figure shows the co-authorship network connecting the top 25 collaborators of Grant Fullarton. A scholar is included among the top collaborators of Grant Fullarton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant Fullarton. Grant Fullarton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glen, Paul, Ian Penman, Neil Cruickshank, et al.. (2024). National adoption of an esophageal cell collection device for Barrett’s esophagus surveillance: impact on delay to investigation and pathological findings. Diseases of the Esophagus. 37(5). 3 indexed citations
2.
Glen, Paul, Ian Penman, Neil Cruickshank, et al.. (2024). Oesophageal cell collection device and biomarker testing to identify high-risk Barrett's patients requiring endoscopic investigation. British journal of surgery. 111(5). 4 indexed citations
3.
Wilson, Christina, Janet Graham, JEFF EVANS, et al.. (2019). The downstaging approach to irresectable oesophageal and gastric cancer: a single centre experience. Journal of Gastrointestinal Oncology. 10(3). 499–505. 1 indexed citations
4.
Evans, Jonathan J., David E. McIntosh, Derek Grose, et al.. (2016). P-080 Incidence of thrombo-embolism (TE) during neo-adjuvant chemotherapy in patients (pts) with oesophago-gastric adenocarcinoma (OGC): implications for surgery and survival. Annals of Oncology. 27. ii24–ii24. 4 indexed citations
5.
Banks, Melissa, Abhinav Gupta, Grant Fullarton, et al.. (2014). PTU-171 Recurrence After Successful Radiofrequency Ablation For Barrett’s Related Neoplasia Is More Likely In Males: Data From The United Kingdom Patient Registry. Gut. 63(Suppl 1). A113.2–A114. 1 indexed citations
9.
Dutta, Sumanta, Andrew Crumley, Grant Fullarton, Paul G. Horgan, & Donald C. McMillan. (2012). Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. The American Journal of Surgery. 204(3). 294–299. 77 indexed citations
10.
Dutta, Sumanta, et al.. (2011). A Comparison of POSSUM and GPS Models in the Prediction of Post-operative Outcome in Patients Undergoing Oesophago-gastric Cancer Resection. Annals of Surgical Oncology. 18(10). 2808–2817. 37 indexed citations
11.
Pereira, Stephen P., Lakshmana Ayaru, Roger Ackroyd, et al.. (2010). The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy. Alimentary Pharmacology & Therapeutics. 32(6). 821–827. 10 indexed citations
12.
Gray, Joanna & Grant Fullarton. (2007). The current role of photodynamic therapy in oesophageal dysplasia and cancer. Photodiagnosis and Photodynamic Therapy. 4(3). 151–159. 22 indexed citations
13.
Gray, Joanna, et al.. (2007). Porfimer sodium photodynamic therapy in the treatment of early oesophageal carcinoma. Photodiagnosis and Photodynamic Therapy. 4(4). 244–248. 5 indexed citations
14.
O’Donnell, Catherine, et al.. (2002). Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. British journal of surgery. 89(8). 985–992. 58 indexed citations
15.
Fullarton, Grant, et al.. (1992). Controlled study of the effect of nicardipine and ceruletide on the sphincter of Oddi.. Gut. 33(4). 550–553. 13 indexed citations
16.
Fullarton, Grant & William R. Murray. (1992). Evaluation of Endoscopic Sphincterotomy in Sphincter of Oddi Dysfunction. Endoscopy. 24(3). 199–202. 22 indexed citations
17.
Fullarton, Grant, et al.. (1991). Controlled study of the effects of intravenous famotidine on intragastric pH in bleeding peptic ulcers. Alimentary Pharmacology & Therapeutics. 5(1). 77–84. 19 indexed citations
18.
Fullarton, Grant, et al.. (1990). Effect of simulated intragastric haemorrhage on gastric acid secretion, gastric motility, and serum gastrin.. Gut. 31(5). 518–521. 4 indexed citations
20.
Murray, William R., Godfrey LaFerla, & Grant Fullarton. (1988). Choledocholithiasis--in vivo stone dissolution using methyl tertiary butyl ether (MTBE).. Gut. 29(2). 143–145. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026